Financials Boditech Med Inc.

Equities

A206640

KR7206640005

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E. 06:00:00 2024-05-19 pm EDT 5-day change 1st Jan Change
17,390 KRW +0.12% Intraday chart for Boditech Med Inc. +5.20% -15.17%

Valuation

Fiscal Period: December 2019 2020 2022 2023 2024 2025
Capitalization 1 221,593 545,546 225,170 450,360 382,037 -
Enterprise Value (EV) 2 221.6 545.5 225.2 383.3 309 297
P/E ratio 19 x 12 x 9.49 x 17.4 x 12.9 x 10.5 x
Yield - - - 0.98% 0.86% 0.86%
Capitalization / Revenue - 3.79 x - 3.33 x 2.56 x 2.08 x
EV / Revenue - 3.79 x - 2.84 x 2.07 x 1.62 x
EV / EBITDA - - - 11.7 x 7.02 x 5.45 x
EV / FCF - - - 12.9 x 13.4 x 10.1 x
FCF Yield - - - 7.75% 7.44% 9.93%
Price to Book - - - 2.42 x 1.9 x 1.63 x
Nbr of stocks (in thousands) 22,963 23,019 21,968 21,969 21,969 -
Reference price 3 9,650 23,700 10,250 20,500 17,390 17,390
Announcement Date 3/30/20 2/17/21 3/20/23 2/19/24 - -
1KRW in Million2KRW in Billions3KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2022 2023 2024 2025
Net sales 1 - 144.1 - 135.2 149.1 183.3
EBITDA 1 - - - 32.69 44 54.5
EBIT 1 - 65.51 - 28.64 37.2 46.5
Operating Margin - 45.45% - 21.19% 24.95% 25.37%
Earnings before Tax (EBT) 1 - - - 31.89 41 51
Net income 1 11.65 47.7 24.15 27.41 32 39
Net margin - 33.1% - 20.27% 21.46% 21.28%
EPS 2 507.0 1,976 1,080 1,181 1,347 1,660
Free Cash Flow 3 - - - 29,695 23,000 29,500
FCF margin - - - 21,966.26% 15,425.89% 16,093.84%
FCF Conversion (EBITDA) - - - 90,836.71% 52,272.73% 54,128.44%
FCF Conversion (Net income) - - - 108,347.61% 71,875% 75,641.03%
Dividend per Share 2 - - - 200.0 150.0 150.0
Announcement Date 3/30/20 2/17/21 3/20/23 2/19/24 - -
1KRW in Billions2KRW3KRW in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 - 35.89 33.1 36.5 38.5 41.5
EBITDA - - - - - -
EBIT 1 - 6.903 5.9 8.5 10.5 11.2
Operating Margin - 19.23% 17.83% 23.29% 27.27% 26.99%
Earnings before Tax (EBT) - - - - - -
Net income 9.237 - - - - -
Net margin - - - - - -
EPS 420.0 - - - - -
Dividend per Share - - - - - -
Announcement Date 11/14/23 2/19/24 5/7/24 - - -
1KRW in Billions
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2022 2023 2024 2025
Net Debt 1 - - - - - -
Net Cash position 1 - - - 67 73 85
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 2 - - - 29,695 23,000 29,500
ROE (net income / shareholders' equity) - 47.1% - 15% 15.7% 16.8%
ROA (Net income/ Total Assets) - - - 12.3% 13.2% 15.7%
Assets 1 - - - 223.7 242.4 249.2
Book Value Per Share 3 - - - 8,476 9,172 10,663
Cash Flow per Share 3 - - - 1,561 2,065 2,607
Capex 1 - - - 4.6 7 11
Capex / Sales - - - 3.41% 4.69% 6%
Announcement Date 3/30/20 2/17/21 3/20/23 2/19/24 - -
1KRW in Billions2KRW in Million3KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
17,390 KRW
Average target price
26,000 KRW
Spread / Average Target
+49.51%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A206640 Stock
  4. Financials Boditech Med Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW